BioMarin Pharmaceutical Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2021
BioMarin Pharmaceutical Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported total net Revenue was $501,693,000 against $429,485,000 a year ago. Income from operations was $11,672,000 against loss from operations of $40,945,000 a year ago. Net income was $12,941,000 against net loss of $29,183,000 a year ago. Basic per share was $0.07 against basic loss per share of $0.16 a year ago. Diluted per share was $0.07 against diluted loss per share of $0.16 a year ago.
For the six months, the company reported total net Revenue was $987,723,000 against $931,554,000 a year ago. Income from operations was $36,758,000 against $64,016,000 a year ago. Net income was $30,312,000 against $52,198,000 a year ago. Basic per share was $0.17 against $0.29 a year ago. Diluted per share was $0.16 against $0.28 a year ago.